Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
0.590
-0.000 (-0.02%)
Mar 9, 2026, 4:00 PM EDT - Market closed

Basel Medical Group Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
1133---
Enterprise Value
729---
Last Close Price
0.591.78---
PS Ratio
1.173.52---
PB Ratio
2.908.75---
P/TBV Ratio
2.908.76---
EV/Sales Ratio
0.773.10---
Debt / Equity Ratio
1.041.040.761.312.74
Debt / EBITDA Ratio
--1.842.823.34
Debt / FCF Ratio
--2.282.783.76
Net Debt / Equity Ratio
-0.97-0.970.491.082.29
Net Debt / EBITDA Ratio
4.194.191.412.903.42
Net Debt / FCF Ratio
0.310.311.472.273.14
Asset Turnover
0.730.730.660.61-
Inventory Turnover
39.8139.8170.6667.92-
Quick Ratio
1.151.150.550.630.63
Current Ratio
1.231.232.262.282.18
Return on Equity (ROE)
-194.56%-194.56%31.77%38.79%-
Return on Assets (ROA)
-4.67%-4.67%10.18%7.77%-
Return on Invested Capital (ROIC)
-977.21%-21.82%19.67%14.21%16.72%
Return on Capital Employed (ROCE)
-20.10%-20.10%28.20%22.50%25.50%
Earnings Yield
-85.66%-28.39%---
FCF Yield
-108.87%-36.13%---
Buyback Yield / Dilution
-15.60%-15.60%---
Source: S&P Capital IQ. Standard template. Financial Sources.